June 17, 2021 04:35 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Fire breaks out on ninth floor of Delhi's AIIMS, no injuries reported | More than 32 lakh vaccine doses administered across country so far: Centre | Nine more cities in India receive Russia's Sputnik V vaccines | BJP's BL Santosh arrives in Tripura to prevent exodus to TMC | Ahead of possible third COVID-19 wave, Delhi to have 5,000 health assistants: Arvind Kejriwal

US FDA denies India’s Covaxin emergency use approval; seeks additional clinical trial data

Hyderabad/UNI:India’s indigenous Covid vaccine ‘Covaxin’ developed by Hyderabad-based Bharat Biotech (BB), will be delayed to launch in the US market as US Food and Drug Administration (FDA) asked ‘Ocugen Inc ‘ the US partner of the BB, to pursue a biological Applications (BLA) path for ‘Covaxin,’ which is full approval.

US health regulator calls for pause in Johnson & Johnson vaccine use after cases of rare blood clots

Washington/IBNS: US's federal health officials on Tuesday called for a pause in the use of the Johnson & Johnson coronavirus vaccine after several cases of a rare and severe type of blood clot were reported among 6.8 million people who received the vaccine.